KR102413408B1 - 장내 미생물 조성에 영향을 미치는 미생물 카로티노이드 - Google Patents

장내 미생물 조성에 영향을 미치는 미생물 카로티노이드 Download PDF

Info

Publication number
KR102413408B1
KR102413408B1 KR1020197001707A KR20197001707A KR102413408B1 KR 102413408 B1 KR102413408 B1 KR 102413408B1 KR 1020197001707 A KR1020197001707 A KR 1020197001707A KR 20197001707 A KR20197001707 A KR 20197001707A KR 102413408 B1 KR102413408 B1 KR 102413408B1
Authority
KR
South Korea
Prior art keywords
intestinal
microbial
carotenoids
carotenoid compound
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197001707A
Other languages
English (en)
Korean (ko)
Other versions
KR20190039687A (ko
Inventor
샘 포세미어스
신디 듀이스버그
아이리스 핀헤이로
셀린 볼카
피터 반 덴 아벨레
마시모 마조라티
Original Assignee
마이크로바이얼 리서치 매니지먼트 헬스 엔브이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마이크로바이얼 리서치 매니지먼트 헬스 엔브이 filed Critical 마이크로바이얼 리서치 매니지먼트 헬스 엔브이
Publication of KR20190039687A publication Critical patent/KR20190039687A/ko
Application granted granted Critical
Publication of KR102413408B1 publication Critical patent/KR102413408B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020197001707A 2016-06-22 2017-06-22 장내 미생물 조성에 영향을 미치는 미생물 카로티노이드 Active KR102413408B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16175832.1 2016-06-22
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (2)

Publication Number Publication Date
KR20190039687A KR20190039687A (ko) 2019-04-15
KR102413408B1 true KR102413408B1 (ko) 2022-06-27

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197001707A Active KR102413408B1 (ko) 2016-06-22 2017-06-22 장내 미생물 조성에 영향을 미치는 미생물 카로티노이드

Country Status (12)

Country Link
US (1) US11324717B2 (enExample)
EP (1) EP3474862B1 (enExample)
JP (1) JP6966543B2 (enExample)
KR (1) KR102413408B1 (enExample)
CN (1) CN109641006B (enExample)
AU (1) AU2017281589B2 (enExample)
BR (1) BR112018076485A8 (enExample)
CA (1) CA3028031C (enExample)
IL (1) IL263683B (enExample)
MX (1) MX390386B (enExample)
RU (1) RU2759600C2 (enExample)
WO (1) WO2017220708A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114949001A (zh) 2012-08-29 2022-08-30 加州理工学院 孤独症谱系障碍的诊断和治疗
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR20170086492A (ko) 2014-10-30 2017-07-26 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법
KR20190127710A (ko) * 2017-02-07 2019-11-13 캘리포니아 인스티튜트 오브 테크놀로지 헌팅톤병 및 레트 증후군에서의 장 미생물총의 조정
MX2020005875A (es) 2017-12-05 2020-10-08 Bioplx Inc Métodos y composiciones para prevenir la infección microbiana.
WO2020043797A1 (en) * 2018-08-29 2020-03-05 Dsm Ip Assets B.V. Formulations for improving gut health
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
WO2025262090A1 (en) 2024-06-18 2025-12-26 Dsm Ip Assets B.V. Combination of carotenoids and inulin and uses thereof
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066108A1 (en) * 2005-12-06 2007-06-14 Royal Holloway And Bedford New College Bacterial production of carotenoids
WO2012017199A1 (en) * 2010-08-03 2012-02-09 Royal Holloway And Bedford New College Et Al Fatty acid esters of carotenoid glucosides as colouring agents for foodstuffs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066108A1 (en) * 2005-12-06 2007-06-14 Royal Holloway And Bedford New College Bacterial production of carotenoids
WO2012017199A1 (en) * 2010-08-03 2012-02-09 Royal Holloway And Bedford New College Et Al Fatty acid esters of carotenoid glucosides as colouring agents for foodstuffs

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Charlotte SY et al., Marine Drugs, 2015, vol.13, no.12, 7020-7039쪽
H.A.Hong et al., J. of Applied Microbiology, 2008, vol.105, no.2, 510-520쪽
Kaulmann et al., Nutrition Resarch, 2014, vol.34, no.11, 907-929쪽.
Kazutoshi Shindo et al., J. of Antibiotics, 2008, vol.61, no.12, 729-735쪽
Laua Perez-Fons et al., Biochimica et Biophtsica acta, 2010, vol.1811, no.3, 177-185쪽

Also Published As

Publication number Publication date
RU2019101481A3 (enExample) 2020-10-16
BR112018076485A2 (pt) 2019-04-09
JP2019524877A (ja) 2019-09-05
IL263683B (en) 2022-04-01
KR20190039687A (ko) 2019-04-15
US20190209516A1 (en) 2019-07-11
US11324717B2 (en) 2022-05-10
RU2759600C2 (ru) 2021-11-16
BR112018076485A8 (pt) 2022-12-06
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
CA3028031C (en) 2023-02-28
JP6966543B2 (ja) 2021-11-17
RU2019101481A (ru) 2020-07-22
CN109641006A (zh) 2019-04-16
EP3474862A1 (en) 2019-05-01
CN109641006B (zh) 2022-07-01
AU2017281589A1 (en) 2019-01-31
CA3028031A1 (en) 2017-12-28
MX390386B (es) 2025-03-20
EP3474862B1 (en) 2025-10-29
AU2017281589B2 (en) 2023-03-23
IL263683A (en) 2019-01-31

Similar Documents

Publication Publication Date Title
EP3474862B1 (en) Microbial carotenoids affecting gut microbial composition
JP6608047B2 (ja) 多様な機能性を有する新規乳酸菌およびその用途
JP6954563B2 (ja) 代謝障害を処置するための低温殺菌アッカーマンシアの使用
Vendrame et al. Six-week consumption of a wild blueberry powder drink increases bifidobacteria in the human gut
Honda et al. Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice
CN102548566B (zh) 植物乳杆菌菌株用作降血胆固醇试剂
Faghfoori et al. Cellular and molecular mechanisms of probiotics effects on colorectal cancer
KR101807328B1 (ko) 경구용 ｄｎａ 손상 수복 촉진제 및 엘라스타아제 활성 억제제
KR102084825B1 (ko) 유아의 과도한 울음용 프로바이오틱
JP6734472B2 (ja) ラクトバチルス・アシドフィルスを含む更年期の予防または治療用組成物
Chen et al. Kefir microbiota and metabolites stimulate intestinal mucosal immunity and its early development
Song et al. Lactiplantibacillus plantarum DLPT4 protects against cyclophosphamide-induced immunosuppression in mice by regulating immune response and intestinal flora
JP2019524132A (ja) ラクトバチルス・インテスティナーリスを含む更年期の予防または治療用組成物
Han et al. Postbiotics ameliorate DSS-induced colitis in mice by regulating gut microbiota, promoting tryptophan metabolism, and activating AhR/IL-22 signaling pathway
FR3114106A1 (fr) Souche bactérienne appartenant au genre Christensenella et compositions
Borgonovi Biocompostos de buriti e maracujá: perfil, aplicação em leite fermentado probiótico e modulação da microbiota in vitro
Minuto From youth to old age: therapeutic potential of microbiota interventions in the gut-brain-axis
da FONSECA et al. The function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis: a systematic review.
AU2023381392A1 (en) Compositions
McCarville Effects of prebiotic fibre diets on rat mucosal intestinal and systemic immunity and in vitro mechanistic analysis of anti-inflammatory effects of Lactobacillus strains on rat and human intestinal epithelial cells
Giuliani Administration of polyphenols-based botanicals: influence of intestinal microbiota’s metabolism, functionality and composition in in vitro simulation technology SHIME®.
Panda Development of probiotic chocolate from bael
Al-Nabulsi et al. Health Benefits of Symbiotic Functional Food Products

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190117

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200609

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20211029

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220324

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20220614

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220622

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220622

End annual number: 3

Start annual number: 1

PG1601 Publication of registration